BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2718584)

  • 1. [HbA1 and glycosylated serum proteins in type I diabetic patients].
    Gottschling HD; Pusch H; Michaelis D
    Z Med Lab Diagn; 1989; 30(1):70-2. PubMed ID: 2718584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of serum fructosamine in the metabolic control of children and adolescents with type I diabetes mellitus].
    Krause M; Pfüller H; Herbst D; Kruse K
    Monatsschr Kinderheilkd; 1987 Apr; 135(4):200-3. PubMed ID: 3600671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U; Sedlmayer A; Müller MM; Dorda W; Schernthaner G
    Klin Wochenschr; 1989 Apr; 67(7):379-85. PubMed ID: 2747138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in young adults with insulin-dependent diabetes.
    Fisken RA; Chan AW; Hanlon A; MacFarlane IA
    Clin Chim Acta; 1990 Oct; 191(1-2):79-86. PubMed ID: 2073735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
    Gómez Reyes D; Gea T; Rojas Hidalgo E
    Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluctuations in albumin on serum fructosamine assay.
    McCance DR; Coulter D; Smye M; Kennedy L
    Diabet Med; 1987; 4(5):434-6. PubMed ID: 2959433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of glycosylated blood proteins and blood glucose profiles over one year in patients with type 1 diabetes.
    Winocour PH; Bhatnagar D; Kalsi P; Hillier VF; Anderson DC
    Diabet Med; 1989 Nov; 6(8):709-16. PubMed ID: 2532106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.
    Parfitt VJ; Clark JD; Turner GM; Hartog M
    Diabet Med; 1993 Mar; 10(2):162-6. PubMed ID: 8458194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of fructosamine determination in diabetic patients and its relation to metabolic control.
    Daubresse JC; Laurent E; Ligny C; Bailly A; Lemy C; Duchateau A; Meunier JC
    Diabete Metab; 1987 Jun; 13(3):217-21. PubMed ID: 3609423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
    Steen G; Weber RF
    Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated haemoglobin and glycated protein and glucose concentrations in necropsy blood samples.
    John WG; Scott KW; Hawcroft DM
    J Clin Pathol; 1988 Apr; 41(4):415-8. PubMed ID: 3366927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein glycation as measured by fructosamine assay.
    Mosca A; Carenini A; Zoppi F; Carpinelli A; Banfi G; Ceriotti F; Bonini P; Pozza G
    Clin Chem; 1987 Jul; 33(7):1141-6. PubMed ID: 3594841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylated hemoglobin and fructosamine. Indicators of glycemic control in pregnancies complicated by diabetes mellitus.
    Watson WJ; Herbert WN; Prior TW; Chapman JF
    J Reprod Med; 1991 Oct; 36(10):731-4. PubMed ID: 1956013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a change in posture on the diurnal variations of fructosamine concentration in diabetic patients].
    Willms B; Schumann E
    Wien Klin Wochenschr Suppl; 1990; 180():44-8; discussion 57-9. PubMed ID: 2321392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.